Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC)

NCT07460999 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2026-03-01
Last updated
2026-04-02

Condition(s) studied

Non-Small Cell Lung CancerChronic Obstructive Lung Disease

Investigational drug(s) / intervention(s)

Singing training (Singing for Lung Health (SLH))Control group: Usual care

Singing training (Singing for Lung Health (SLH)): 10 weeks of singing training (conducted according to the Singing for Lung Health (SLH) approach). The singing training will be delivered online (1 1/2 hour twice a week) by professional singing teachers specifically trained and experienced within SLH. Sessions include physical, vocal, and breathing exercises and musical repertoire. Besides, movement, dancing, and artefacts for playful games are included along with singing. Each session consists of 20 min physical warm-ups, 20 min vocal warm-up with rhythm and pitch games, 40 min singing (incl. break), and 10 min cool-down.

Control group: Usual care: The control group will receive usual care, i.e., no specific additional intervention above those which the person usually engages with.

Study summary

People who have undergone curative surgery for non-small cell lung cancer (NSCLC) often experience reduced quality of life (QoL), a high burden of symptoms, and physical deconditioning. Current Danish rehabilitation offers are heterogeneous and inconsistent and not tailored to the specific needs of this population. Additionally, some patients continue to suffer from persistent physical symptoms months or even years after surgery, yet no targeted support is currently available for them. Singing - delivered as a structured form of training - has shown benefits in improving both physical and psychological outcomes in individuals with chronic obstructive pulmonary disease (COPD). Although singing has not yet been studied in NSCLC patients, the two conditions share overlapping symptoms and characteristics. Therefore, the present study aims to explore whether a singing-based intervention can help reduce symptom burden and improve physical function and QoL in NSCLC patients 6 to 18 months post-surgery. To test this, a multi-centre randomised controlled trial (RCT) will be conducted, comparing a singing intervention to usual care. Given that travel and distance often pose significant barriers to participation, the intervention will be delivered online.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: Patients who display persistent symptoms 6-18 months (+/- one month) after surgical resection of localised lung cancer with video-assisted thoracoscopy (VATS) will be invited to participate in the study. Inclusion criteria for the study include: 1. Persistent symptoms, i.e., an EORTC-QLQ-C30 symptom domain score (in any item) of ≥2 (="clinically relevant symptom or problem that should have healthcare professional attention"), 2. Surgery for stage I lung cancer 6-18 months (+/- one month) earlier, 3. Motivated for participating in the project (and acceptance of randomisation procedure), 4. Access to a computer or a tablet with internet access, 5. Ability to speak and understand Danish, 6. Acceptance of the scheduled times of the singing intervention twice a week. Exclusion Criteria: Exclusion criteria include: 1. Unstable coronary diseases, 2. Severe cognitive disabilities (e.g., dementia), 3. Indication for adjuvant chemotherapy or other antineoplastic therapy, 4. Signs of lung cancer recurrence at regular follow-up CT scan. No previous singing experience or musical competence is required. Participants will be informed that they are allowed to participate in additional offer of structured or unstructured offer physical exercise training and/or singing along with the project.

Primary outcome measure(s)

  • Change in Physical capacity — Changes pre-post 10 weeks (measured at all assessment points).
    Assessed with the Six Minute Walking Test (6MWT) (assessor-collected) , measured in meters walked in 6 minutes. Minimal important difference: \>30 m.
  • Perceived exertion — Changes measured before and after performance of 6MWT; Changes pre-post 10 weeks (measured at all assessment points).
    Measured using BORG CR-10 dyspnoea scale (self-reported). The scale ranges from 0 to 10 points, where 0 represents no exertion/dyspnoea and 10 represents maximal exertion/dyspnoea. Minimal important difference: 1 point.
  • Change in Health-related quality of life (HRQoL) — Changes pre-post 10 weeks (measured at all assessment points).
    St. George's Respiratory Questionnaire (SGRQ) (self-reported questionnaire). SGRQ has 50 items with 76 weighted responses and four scores: Total, Symptom, Activity, Impact. Each score ranges from 0 to 100, with 100 representing worst possible health status and 0 best possible. Minimal important differnence: -4 units.

Trial sites (5)

FacilityCityRegionStatus
August Krogh Section for Molecular and Human Physiology, Department of Nutrition, Exercise, and Sports, Faculty of Health and Medical Sciences, University of Copenhagen Copenhagen Denmark Recruiting
Department of Respiratory Medicine, Bispebjerg Hospital Copenhagen Denmark Recruiting
Department of Medicine Roskilde and Næstved, Zealand University Hospital Næstved Denmark Recruiting
Department of Respiratory Medicine, Odense University Hospital Odense Denmark Recruiting
Department of Respiratory Medicine, Lillebaelt Hospital Vejle Denmark Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07460999 on ClinicalTrials.gov ↗ ← All trials in Denmark